x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

AI For Pharma Growth

Dr Andree Bates

AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to

technology entrepreneurship

All Episodes

22:32

E188: How AI is Used in Digital Marketing

AI For Pharma Growth ·

2025/10/21

In this episode, we dive deep into how artificial intelligence (AI) is revolutionising digital marketing, from SEO optimisation to automated content creation, predictive analytics, and personalised campaigns.Our guest, Brandon Leibowitz, founder of SEO Optimisers, shares his expert insights on the future of AI-powered marketing, the best AI tools for SEO, and how to write effective ChatGPT prompts that actually rank.You’ll learn how marketers are using AI and machine learning to:Boost search engine

en

26:22

E187: Digital Guardians: Where AI Meets Cybersecurity

AI For Pharma Growth ·

2025/10/14

In this episode, we dive into the escalating war between AI and cybercrime — where artificialintelligence is both the ultimate defense and the greatest vulnerability.Our guest, Grant McCracken, founder of Dark Horse Security, reveals how AI-driven cybersecurity, machine learning detection systems, and automated threat analysis are transforming how we fight cyber threats in real time.From deepfake social engineering scams to AI-powered malware that learns and evolves, this conversation explores how

en

33:24

E186: How Manufacturing Innovation is Making...

AI For Pharma Growth ·

2025/10/07

Carlo Buckley, Founder and CEO of ID Health, joins the show to reveal how his company is transforming the future of personalised medicine through AI-driven, automated pharmaceutical manufacturing.For decades, personalised medicine has been limited by outdated manufacturing methods designed for mass production, not individual treatment. ID Health is changing that — pioneering a new way to produce personalised, patient-specific capsules at scale and at cost, combining multiple medications into one

en

32:06

E185: Use of xAI in Small Cohort Clinical Trials to...

AI For Pharma Growth ·

2025/09/30

In this episode, we explore how Explainable AI (XAI) is revolutionizing drug development, rare disease research, and precision medicine.Our guest, Frédéric Parmentier, Vice President of Data Science at Ariana Pharma, shares how their Explainable Artificial Intelligence (XAI) platform, KEM (Knowledge Extraction and Management), helps uncover critical biomarker signatures in small cohort clinical trials. Unlike traditional black box AI models, XAI delivers transparent, interpretable results that

en

25:27

How Contactless AI Sleep Monitoring is Transforming...

AI For Pharma Growth ·

2025/09/23

How can AI-powered sleep monitoring transform clinical trials, drug development, and healthcare at home?In this episode, Jonas Krauss, Vice President of Business at Sleepiz AG, joins us to explore how contactless AI monitoring is redefining the way researchers and clinicians collect and analyze sleep data, vital signs, and patient health trends.Using radar-based sensors and artificial intelligence algorithms, Sleepiz can track breathing, heart rate, and sleep stages with medical-grade accuracy — all

en

34:32

Accelerating Biomanufacturing with AI: Reducing...

AI For Pharma Growth ·

2025/09/16

Can artificial intelligence really cut biomanufacturing timelines from years to hours? The answer is yes — and it’s already happening.In this episode, we sit down with Justin Byers, founder and CEO of Axio BioPharma, to explore how AI-driven biomanufacturing is transforming the development of monoclonal antibodies, biologics, and vaccines. By leveraging machine learning, digital twins, and predictive modeling, Axio is slashing development costs, reducing failure rates, and accelerating drug

en

21:39

Why Clinical Drug Development Keeps Failing

AI For Pharma Growth ·

2025/09/09

Over 90% of drugs fail during clinical development, costing billions and leaving patients without life-saving treatments. Why does the pharmaceutical industry face such a high drug development failure rate, and how can artificial intelligence change the story?In this episode, Vitalay Fomin, CEO and co-founder of Numenos AI, reveals how his team is rethinking clinical trials, biomarker discovery, and drug development with advanced AI technologies designed to predict patient response, reduce

en

33:34

The future of IP Law: What's Next for Trademarks,...

AI For Pharma Growth ·

2025/09/02

As artificial intelligence transforms the way we create, invent, and innovate, it’s also forcing the legal world to face unprecedented challenges. In this episode, Dr. Don Simmonds, IP law expert and founder of IPITEC, dives deep into the future of intellectual property law in the age of AI.From AI-generated art and machine-written books to patent disputes over AI-created inventions, this conversation unpacks the complex legal questions around AI copyright, AI patent law, and ownership rights in

en

37:48

E180: Pharma and AI: Drug Discovery with Confidential...

AI For Pharma Growth ·

2025/08/26

In this cutting-edge episode, we explore how Edge AI is transforming drug discovery and revolutionising laboratory workflows, real-time molecular analysis, and protein folding predictions—all at the source of data collection. Joining us is Nuri Cankaya, Vice President of Commercial Marketing at Intel Corporation, and a renowned thought leader in AI and healthcare innovation.You'll discover how AI at the edge—enabled by on-device NPUs, GPUs, and CPUs—is unlocking privacy-preserving, high-performance

en

30:20

E179: Beyond Anonymization: Why Traditional Privacy...

AI For Pharma Growth ·

2025/08/19

In this eye-opening episode, we sit down with Julia Komissarchik, CEO and Co-Founder of Glendor Inc., to explore the rapidly evolving intersection of AI in healthcare, medical data privacy, and patient data protection. With AI transforming clinical decision-making, diagnostics, and health research, traditional privacy approaches like de-identification are no longer sufficient.Julia, a seasoned expert in AI and a multi-patent holder, explains why anonymised health data is still vulnerable to

en

27:54

E178: Navigating Reliability in Modern Molecular...

AI For Pharma Growth ·

2025/08/12

Can AI truly revolutionize molecular biology if it’s built on unreliable data? In this game-changing episode, we speak with Dr. Jonathon O'Brien, founder and CEO of Golgi, about one of the most critical—and often overlooked—issues in biomedical AI: data reliability.With a background in biostatistics, proteomics, and machine learning, Dr. O’Brien shares how Golgi’s AI-powered computational platform is helping pharma and biotech giants like Johnson & Johnson tackle the reproducibility crisis in

en

28:40

E177 | Maximising Healthcare Value with Real World Data

AI For Pharma Growth ·

2025/08/05

In this episode, we delve into the transformative power of real-world data (RWD) in modern healthcare. Our guest, Ted Sweetser, Vice President of Strategic Advertising and Partnerships at PurpleLab, shares expert insights on how real-world data is driving innovation in patient outcomes, market access, and public health strategy.From electronic health records (EHRs) and insurance claims data to wearable health technology and social determinants of health (SDOH), this conversation explores how diverse

en

32:29

E176 | FDA Guidance on AI in Drug Development &...

AI For Pharma Growth ·

2025/07/29

In this episode, former FDA leader and current SVP of Regulatory and Quality at Ariana Data Intelligence, Dr. Frederico Goodsaid, shares cutting-edge insights on how artificial intelligence (AI) is reshaping the landscape of drug discovery and development — particularly in the treatment of rare and orphan diseases.From breaking down the FDA's new guidance on AI to explaining why credibility now matters more than explainability, this conversation offers essential takeaways for professionals in

en

34:53

E175 | Technology and Human Evolution

AI For Pharma Growth ·

2025/07/22

Why empathy, ethics, and education must remain central to AI adoptionPredictions for the next 500 years of human-AI co-evolutionThis conversation blends AI philosophy, tech strategy, and personal productivity in a way that will challenge your assumptions and give you actionable ideas to stay relevant in the AI-pIn this eye-opening episode, we’re joined by Mark Andrews, founder and CEO of AI Prophets, for a deep-dive into how artificial intelligence (AI) is transforming human evolution, cognition,

en

27:26

E174 | How AI is Transforming Regulatory Submission...

AI For Pharma Growth ·

2025/07/15

In this powerful episode, we dive deep into how artificial intelligence (AI) and automation are transforming regulatory submissions and medical writing in the biopharmaceutical industry.Our guest, Tim Martin, Vice President of Product at Yseop, shares expert insights on how AI-driven tools are revolutionising workflows, cutting document creation times by over 70%, and helping accelerate drug approval timelines — potentially saving $1–$5 million per day for pharma companies.In this episode, you’ll

en

44:03

E173 | How AI is changing/revolutionizing drug discovery

AI For Pharma Growth ·

2025/07/08

In this episode, we sit down with Dr. Marschall Runge - CEO of Michigan Medicine and Dean of the University of Michigan Medical School - to explore how artificial intelligence (AI) is transforming the entire landscape of drug discovery, clinical trial design, and precision medicine.With deep insights from decades of leadership across biotechnology, genomics, and translational research, Dr. Runge shares exclusive stories on how pharmaceutical giants and biotech startups are using AI to compress years

en

29:10

E172 | The problems that modern AI methods have with...

AI For Pharma Growth ·

2025/07/02

Thispowerful episode dives into one of the most urgent issues in modern healthcare; how current AI systems in clinical trials are missing the mark for diverse and underrepresented patient populations, especially in oncology and neurology.Guest Dr. Joseph Geraci, mathematician, quantum machine learning scientist, and inventor of Netramark, breaks down how most AI models today are built on biased, homogeneous datasets - and what needs to change to truly unlock the potential of precision medicine.In

en

32:01

E171 | Leveraging AI to detect mental states and...

AI For Pharma Growth ·

2025/06/24

Leveraging AI to detect mental states and prevent catastrophic events in mental healthThis episode dives into a revolutionary advancement in AI-powered mental health technology. Francois Gand, founder and CEO of Nuro, introduces Mentis - a non-invasive neurotechnology platform capable of detecting, tracking, and predicting mental states in real time.From preventing suicide and catastrophic errors in high-risk professions to enabling communication for the paralyzed, Mentis is a game-changer in

en

30:13

E170 | Leveraging AI for patient finding and...

AI For Pharma Growth ·

2025/06/17

In this expert-led episode, Christopher Rudolf, CEO of Volv Global, unpacks how artificial intelligence is revolutionizing rare disease detection and knowledge generation. With over 30 years in data science and medical informatics, he shares how machine learning is being used to solve two of the biggest challenges in rare disease: finding undiagnosed patients and generating actionable clinical insights.This conversation is essential for professionals in healthcare innovation, data analytics, life

en

29:36

E169 | Scaling Life-Saving AI Through Synthetic Imaging

AI For Pharma Growth ·

2025/06/10

This episode dives deep into how synthetic medical imaging is revolutionizing the development of AI in healthcare. Rayan Sadri, founder and CEO of Carez AI, explains how his team uses diffusion models and GANs to create fully anonymized, regulator-friendly datasets that dramatically accelerate the development of diagnostic tools - even for rare conditions and underserved populations.Discover how synthetic data eliminates the bottlenecks of traditional medical datasets by solving challenges around

en

190 results

Similar Podcasts

Pantomath

PANTOMATH

What"s New

WIRED

Security, Spoken

WIRED

Ben Wehrman Podcast

Ben Wehrman

MacMagazine no Ar

MacMagazine.com.br